ClinicoEconomics and Outcomes Research is a prestigious open-access journal published by DOVE MEDICAL PRESS LTD, located in New Zealand. Since its inception in 2009, it has established itself as a vital resource for researchers and practitioners in the fields of economics, health policy, and outcomes research. With a commendable impact reflected in its rankings—Q1 in Economics, Econometrics and Finance and Q2 in Health Policy—the journal effectively bridges the gap between economic evaluation and healthcare delivery. This publication is particularly significant for those focused on the economic implications of health interventions, policy analysis, and decision-making processes in healthcare systems. As an open-access journal, ClinicoEconomics and Outcomes Research ensures that its valuable content is widely accessible, enhancing knowledge dissemination and fostering collaboration among academia, industry, and policymakers. With an ambition to contribute to the improvement of health outcomes through rigorous research, it invites submissions that address the multifaceted challenges facing the economics of healthcare today. Join the scholarly dialogue where innovative ideas in health economics thrive!

Expert Review of Pharmacoeconomics & Outcomes Research is a leading journal published by TAYLOR & FRANCIS LTD, focusing on the critical intersection of pharmacoeconomics and healthcare outcomes. Established in 2001, the journal has been a key resource for researchers and professionals in the fields of health policy, medicine, and pharmacology, consistently ranked in the top quartile of these categories for its influential insights. With an ISSN of 1473-7167 and an E-ISSN of 1744-8379, it delivers cutting-edge research that informs healthcare decisions and policy frameworks. The journal's rigorous peer-review process ensures the publication of high-quality, impactful articles that address contemporary challenges and advancements in pharmacoeconomic evaluations. As of 2023, it boasts a commendable ranking of #106 in Health Policy and #124 in Pharmacology, affirming its relevance and contribution to the field. Despite being a subscription-based journal, the strength of its content makes it an invaluable tool for researchers and practitioners aiming to enhance patient outcomes and optimize resource allocation in healthcare systems.

The Journal of Demographic Economics, published by Cambridge University Press, stands as a leading interdisciplinary platform dedicated to the exploration and advancement of research in the intertwined fields of demography, economics, and geography. With an impact factor that reflects its esteemed position—ranking in the Q1 quartile for Demography (2023)—the journal fosters scholarly dialogue through high-quality articles that elucidate the complex interactions between population dynamics and economic trends. Operating under an open access model, the journal ensures that its findings are widely accessible, promoting inclusivity and engagement among researchers, professionals, and students alike. The Journal of Demographic Economics endeavors to bridge gaps in knowledge by publishing innovative and rigorous studies, thereby contributing significantly to both theoretical frameworks and practical applications across various domains. Drawing submissions from a global audience, this journal not only enhances the understanding of demographic transitions but also informs policy decisions and socioeconomic development strategies, making it an essential resource for those invested in demographic and economic research.

The Journal of Health Management, published by SAGE PUBLICATIONS INDIA PVT LTD, stands as a pivotal academic platform dedicated to advancing knowledge in the field of health management and policy. Established in 1994, the journal has evolved to encompass a broad spectrum of topics within health services, public health, and health policy, targeting an array of stakeholders including researchers, practitioners, and policymakers. With an ISSN of 0972-0634 and an E-ISSN of 0973-0729, the journal is indexed in Scopus, where it holds respectable rankings in both the Business and Medicine domains, particularly in health policy, affirming its impact and relevance (Ranking: #137/310 with a percentile of 55th). Although it is categorized in the Q3 Health Policy quartile for 2023, the journal is set to play an instrumental role in shaping health management discourse in India and beyond. It offers a rich collection of research articles, reviews, and case studies, with no Open Access charges, making it a valuable resource for academics and practitioners alike who seek to enhance their understanding of health management issues.

Journal of Health Economics and Outcomes Research, published by COLUMBIA DATA ANALYTICS, LLC, serves as a vital resource in the field of health policy and public health, providing researchers, professionals, and students with open access to pioneering studies since its inception in 2013. With its ISSN and E-ISSN both listed as 2327-2236, this journal aims to disseminate high-quality research that evaluates healthcare efficiency and outcomes. Situated in the United States, at 145 Hudson St., Suite 205, New York, NJ 10013, it has made significant strides in its category quartiles within the 2023 rankings, achieving Q2 status in both Health Policy and Public Health, Environmental and Occupational Health. Furthermore, it maintains respectable Scopus rankings, with a percentile of 51st in health policy and 49th in public health. By bridging gaps in health economics and policy discourse, the journal stands as an indispensable platform for advancing knowledge and fostering innovation in health services research.

Introducing the JAMA Health Forum, a premier journal published by the American Medical Association, dedicated to advancing knowledge in the critical fields of health policy and public health. Since its inception in 2020, this open-access journal has emerged as a leading platform for high-quality research, achieving a distinguished Q1 ranking in both Health Policy and Public Health, Environmental and Occupational Health for 2023. With an ISSN of 2689-0186, it provides a vital resource for researchers, policymakers, and students alike, facilitating widespread dissemination of impactful studies that aim to shape health strategies and improve community health outcomes. The JAMA Health Forum not only fosters collaboration among experts but also enhances global discussions on pressing health issues, making it an essential read for anyone involved in health-related research and practice.

Health Economics Policy and Law is a premier journal published by Cambridge University Press that focuses on the intersection of health economics, policy formulation, and legal frameworks. Since its establishment in 2006, the journal has been at the forefront of disseminating high-quality research, covering critical issues in the ever-evolving health policy landscape. With an impressive impact factor and ranked in the Q1 category of Health Policy according to the latest metrics (2023), it serves as a vital resource for academic researchers, professionals, and students alike. The journal aims to stimulate discussion and influence decision-making by providing rigorous empirical studies, policy analyses, and theoretical evaluations. While not open access, its publications are accessible through institutional subscriptions, reflecting its commitment to supporting scholarly discourse within the field. As it continues to converge towards its 2024 goals, Health Economics Policy and Law remains an essential platform for advancing knowledge and fostering innovation in health policy and law.

International Journal of Health Economics and Management is a premier academic journal published by SPRINGER, focusing on innovative research at the intersection of health economics and management practices. Established in 2015, this journal caters to a diverse range of disciplines, integrating rigorous economic analysis with vital health policy discussions. With an impressive impact factor reflective of its influential publications, it holds a distinguished Q1 ranking in Economics, Econometrics, and Finance, and a Q2 ranking in Health Policy for 2023. The journal provides an open access model, enabling wider dissemination of research findings to academics, policymakers, and healthcare professionals globally. Researchers and students alike will find this journal invaluable for its commitment to advancing knowledge in health economics and improving healthcare management practices through empirical studies and theoretical insights. For more information, or to access articles, please refer to the journal's platform.

International Journal for Equity in Health, published by BMC, stands as a pivotal platform within the fields of Health Policy and Public Health, dedicated to advancing knowledge related to health equity and social justice in healthcare systems. With an impressive HIndex and consistently ranking in the Q1 quartile for both health policy and public health categories as of 2023, this journal not only highlights critical research but also positions itself among the top echelons of the academic community, holding a commendable Scopus rank of #27 out of 310 in Health Policy and #71 out of 665 in Public Health, Environmental, and Occupational Health. Since its inception in 2002, and as an Open Access journal, it has been committed to making impactful research widely accessible, fostering a collaborative dialogue among researchers, practitioners, and policymakers globally. Based in the United Kingdom, the journal invites comprehensive submissions that address pressing issues surrounding health equity, and aims to contribute to the formulation of effective health policies that can bridge disparities across diverse populations.

Economics & Human Biology, published by Elsevier, is a prestigious journal that serves as an interdisciplinary platform at the intersection of economics and health sciences. With ISSN 1570-677X and E-ISSN 1873-6130, this journal analyzes the implications of economic factors on human health and biological outcomes. As a recognized leader in its field, it has earned a remarkable Q1 ranking in both the Economics, Econometrics and Finance (miscellaneous) and Health (social science) categories for 2023, reflecting its significant impact within the academic community, as evidenced by its Scopus rank of 88 out of 371 and a 76th percentile ranking in Health social sciences. Highlighting key issues such as health disparities, economic policy impacts on health, and the biological determinants of economic behavior, the journal encourages innovative research that bridges these critical domains. Researchers, professionals, and students seeking to contribute to or stay informed on emerging trends in health economics will find this journal an invaluable resource. Explore the latest findings and engage with a community dedicated to advancing our understanding of the interplay between economics and human biology.